In one embodiment, an end effector assembly for a substrate transfer robot includes an end effector having a plurality of metallic pads disposed thereon.
The desired effector output is compared to an actual effector output to get a distortion metric.
Some embodiments comprise an end effector to treat tissue, where the end effector comprises an ultrasonic blade.
A projected position of the surgical end effector if no force were applied against the end effector is also determined.
An actuation feature is in communication with the end effector and the insert when the insert is received in the end effector.
Copy one job (calculated above).
mechanism which gives rise to the immune reaction
The present invention provides pharmacological compounds including an effector moiety conjugated to a binding moiety that directs the effector moiety to a biological target of interest.
The surgical instrument is connected to the surgical robot and comprises an end effector and a mechanical interface to manipulate the end effector.
The offset between the two images provides a visual indication of a force applied to the end effector or to the kinematic chain that supports the end effector.
The load sensor identifies when the wafer is loaded on the end effector.
A surgical tool includes a tool shaft, and end effector and a wrist that couples the end effector to the tool shaft.
In addition an end-effector may be disposed at the distal end of the elongate member, the end-effector may include a first arm and a second arm.
The end effector includes a splined inner tube rotatably supported in an outer tube; and a plurality of surgical anchors loaded in the inner tube of the end effector.
The system may include a first robot having a surgical tool mounted as an end effector and a second robot having a camera mounted as an end effector.
The end effector assembly may include a transmission assembly, an end effector, and a rotational knob operable to rotate the transmission assembly and the end effector.
The system comprises a first expression unit comprising an effector gene and a promoter therefor operably linked thereto; and a second expression unit.
An end effector (24) fits in any one of the spaces.
The end effector (12) includes a tissue-retaining device (16).
Cathepsin E is a downstream effector of TLR4, wherein when cathepsin E is overexpressed in lung of an individual, the individual is at higher risk of developing emphysema/COPD.
The shaft extends between the body and the end effector.